Protecting the pharmaceutical supply chain

Mobi Health News

Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution.

Pimping the pharmaceutical supply chain

Mobi Health News

Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution.

How Pharmaceutical Companies Can Take Advantage of the EHR Revolution

Electronic Health Reporter

The article How Pharmaceutical Companies Can Take Advantage of the EHR Revolution appeared first on electronichealthreporter.com. Editorial electronic health records formularies are standardized PharmaceuticalThis content is copyrighted strictly for Electronic Health Reporter.

From Pharmaceuticals to Medical Devices: What to Watch in China's Healthcare Sector

Lloyd Price

In the latest episode of our podcast, Exchanges at Goldman Sachs, Stephanie Hui, head of Goldman Sachs' Merchant Banking Division in Asia-Pacific ex-Japan, explains how these dynamics are creating key investment opportunities in the pharmaceuticals, medical equipment and medical services markets. "People

Topical Antibiotic Pharmaceuticals Market – Global Industry Analysis, Size and Forecast, 2016 to 2026

Healthcare Guys

Topical Antibiotic Pharmaceuticals Market: Drivers and Restraints. Global topical antibiotic pharmaceuticals is projected to grow rapidly due to increasing prevalence of skin and soft tissue infections as well as increasing availability and affordability of topical antibiotic products. Major drivers for the topical antibiotic pharmaceuticals market are increasing combination of drugs with different chemical moieties for treating various skin infections.

The United States of Diabetes: a $1,240 Tax on Every American

Health Populi

Pharmaceutical company executives are testifying in the U.S. Congress this week on the topic of prescription drug costs. One of those medicines, insulin, cost a patient $5,705 for a year’s supply in 2016, double what it cost in 2012, according to the Health Care Cost Institute.

Americans’ Trust in U.S. Healthcare Lags Tech — and Women Are Particularly Cynical

Health Populi

Pharmaceuticals garner the lowest score at 57, compared with biotech and life sciences at 64. The 2019 Edelman Trust Barometer measured the biggest gap in trust for the healthcare industry between the U.S. “informed public” and the mass population.

Most Americans Blame Drug Companies, Insurers, and Hospitals for High Health Care Costs

Health Populi

Health Consumers Health costs Health Economics Health insurance Health Plans Health policy Health politics Hospitals Pharmaceutical Prescription drugsThere’s little agreement between Democrats and Republicans on a plethora of issues in American public life. But one issue that brings U.S.

Two-Thirds of Americans Say Healthcare Doesn’t Work Well, in RealClear Politics Poll

Health Populi

Health care is the top issue facing the U.S. today, one in three Americans says, with another one-fourth pointing to the economy. Together, health care + the economy rank the top issues for 62% of Americans.

National Health Spending Will Reach Nearly 20% of U.S. GDP By 2027

Health Populi

National health spending in the U.S. is expected to grow by 5.7%

AHIP18: How Intermountain plans to fight pharmaceutical monopolies as a generic drugmaker

FierceHealthIT

After watching Martin Shkreli raise the price of a drug by more than 550% in 2015, Intermountain's Dan Liljenquist had the same thought as the rest of America: Is this really happening? So the system decided to create a nonprofit generic drug company that Liljenquist calls a “first-of-its-kind societal asset

Across All Political Parties, Likely Voters Over 50 Favor Cutting Prescription Drug Prices

Health Populi

It’s a rational response, then, that 9 in 10 older voters agree that pharmaceutical companies “make too much profits,” once again consistent — equally felt — by older voters across all three political parties, shown in the second bar chart.

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Health Populi

Americans consumed 17.6 prescriptions per person in 2018, two in three of which treated chronic conditions. Welcome to Medicine Use and Spending in the U.S. , the annual review of prescription drug supply, demand and Rx pricing dynamics from the IQVIA Institute for Human Data Science.

Harnessing Innovation to Serve and Create Value for Patients

Electronic Health Reporter

By Georgia Mitsi, PhD, MBA, senior director and head of digital healthcare initiatives, Sunovion Pharmaceuticals Inc. Editorial Georgia Mitsi improving patient care Sunovion PharmaceuticalsThis content is copyrighted strictly for Electronic Health Reporter.

In 2023, the U.S. Will Still Be the #1 Prescription Drug Spender in the World, IQVIA Forecasts

Health Populi

Health Consumers Health costs Health law Health policy Health politics Pharmaceutical Pharmacy Prescription drugs

Costs, Consumerism, Cyber and Care, Everywhere – The 2019 Health Populi TrendCast

Health Populi

Today is Boxing Day and St. Stephens Day for people who celebrate Christmas, so I share this post as a holiday gift with well-wishes for you and those you love.

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Health Populi

That would be profits made by pharmaceutical companies, cited by 80% of respondents. Ironic that in this Congressional session, pharmaceutical manufacturers are testifying about the life-saving benefits of their products, but priced to drive about one-third of Americans not to adopt them.

Employers Take on Health Activism, Embracing Behavioral Health, Virtual Care, AI, and Transparency

Health Populi

One of the most concerning rising cost components in medical trend come from the pharmaceutical supply chain. The vast majority of employers do not believe the current rebate-based system works to reduce pharmaceutical costs, and most welcoming an alternative to rebates. More U.S.

The Cost of Prescription Drugs, Doctors and Patient Access – A View from HIMSS19

Health Populi

But electronic prescribing alone doesn’t solve the Holy Grail challenge for both the pharmaceutical industry and providers: medication adherence.

Health Care for a Typical Working Family of Four in America Will Cost $28,166 in 2018

Health Populi

What could $28,166 buy you in 2018? A new car? A year of your child’s college education? A plot of land for your retirement home? Or a year of healthcare for a family of four?

Americans Growing Health Consumer Muscles and Knowledge: McKinsey

Health Populi

Health Consumers Health costs Medicines Patient engagement Personal health finance Pharmaceutical Pharmacy Popular culture and health

Healthcare’s Profits Will Be Dramatically Redistributed as Care Shifts to Consumers: Accenture

Health Populi

All sectors who are stakeholders in the healthcare ecosystem aren’t created equal, Accenture explains in their report, Healthcare’s future winners and losers.

Technology, Aging and Obesity Drive Healthcare Spending, BEA Finds

Health Populi

Financial health Health Consumers Health costs Health Economics Health policy Heart health Medicare Medicines Mental health Money and health Obesity Personal health finance Pharmaceutical Prescription drugs Prevention Public health Specialty drugs TransparencyThe U.S.

How We Spend Versus What We Get: America’s Healthcare Spending Makes for Poor Health

Health Populi

had the highest pharmaceutical spending per capita of $1,443 versus $749 for the other nations, roughly double. The U.S. spent nearly twice as much as other wealthy countries on healthcare, mostly due to higher prices for both labor and products (especially prescription drugs).

How to Make Healthcare More Intelligent and Trustworthy: Accenture’s Digital Health Tech Vision 2018

Health Populi

“Do no harm” has been the professional and ethical mantra of physicians since the Hippocratic Oath was first uttered by medical students. The origins of that three-word objective probably came out of Hippocrates’ Corpus , which included a few additional words: “to do good or to do no harm.”.

Healthcare Policies We Can Agree On: Pre-Existing Conditions, Drug Prices, and PillPack – the June 2018 KFF Health Tracking Poll

Health Populi

EpiPen pricing mainstreamed the issue of pharmaceutical costs as a democratized (small “d”) issue in 2016, when Mylan grew the cost of a two-pack to about $600. There are countless chasms in the U.S. this moment in social, political, and economic perspectives.

Doing Less Can Be Doing More for Healthcare – the Biggest Takeaway From ASCO 2018

Health Populi

Less can lead to more for so many things: eating smaller portions, lowering sugar consumption, and driving less in favor of walking or cycling come to mind. When it comes to healthcare utilization, doing less can also result in equal or even better outcomes.

Consumers Changing the Channel on Where They Shop for Health

Health Populi

Consumers who have long purchased over-the-counter medicines, anti-dandruff shampoo, whitening toothpaste, and cosmetics-with-benefits at food, drug and mass merchant retailers are switching to other places to shop for health, new data from AT Kearney and GMDC have found.

CVS + Aetna: Inflection Point in US Healthcare, Merger Approved Update

Health Populi

During the hearing, Senator Patty Murray (D-WA) challenged Azar, “As a pharmaceutical executive, you raised drug prices year after year. CVS Health’s acquisition of Aetna was approved this week by U.S.

The US Covered Nearly 50% of Global Oncology Medicine Spending in 2017 – a market update from IQVIA

Health Populi

Cancer Financial health Financial wellness Global Health Health costs Health finance Health policy Medical innovation Medicines Money and health Pharmaceutical Pharmacy Prescription drugs Specialty drugs Sustainability

Rx 2018: A New Era of Specialty Drugs, Telehealth, Mobile Apps and Value, IQVIA Reports

Health Populi

The report pointed especially to hospital and pharmaceutical prices. President Trump made clear on the campaign trail and in his interview with TIME magazine as Person of the Year that pharmaceutical companies’ pricing needed to be reined in using government pressure.

FDA regulations could create digital health opportunities for pharma

Mobi Health News

A new report from PwC predicts that new and proposed FDA regulations could open up doors for pharmaceutical companies looking to develop digital tools.

Self-Care is Healthcare for Everyday People

Health Populi

Patients are the new healthcare payors, and as such, taking on the role of health consumers. In fact, health and wellness consumers have existed since a person purchased the first toothpaste, aspirin, heating pad, and moisturizing cream at retail.

Prescription Drugs: From Costs and Bad Reputation to Civica Rx and Amazon to the Rescue

Health Populi

consumers have long-ranked the pharmaceutical industry relatively low, but above car salespeople and the Federal government. The prices of medicines prescribed in outpatient settings rose, on average. 10.3% in 2018.

Koen Kas, the Gardener of Health Tech Delights

Health Populi

The future of healthcare is not about being sick, Prof. Dr. Koen Kas believes.

What the Pew Data on Americans’ Views on Technology Means for Healthcare

Health Populi

Most Americans say that pharmaceutical manufacturers, banks, advertisers, energy firms, and tech companies have too much power and influence in today’s American economy, according to Public Attitudes Toward Technology Companies , a research report from the Pew Research Center.

European researchers, pharma players team up on gait detecting sensor

Mobi Health News

The European Federation of Pharmaceutical Industries and Associations and researchers across Europe teamed up on a €50 million project to develop a wearable sensor of clinical trials.

Americans’ Trust in the Healthcare System Low Compared to Rest-of-World’s Health Citizens

Health Populi

In the U.S., trust in the healthcare industry declined by 9 percentage points in just one year, declining from 62% of people trusting — that’s roughly two-thirds of Americans — down to 53% — closer to one-half of the population.

Consumers Consider Cost When They Think About Medical Innovation

Health Populi

ACA Affordable Care Act Bio/life sciences Biotech Financial health Financial wellness Health Consumers Health costs Health disparities Health Economics Health finance Health law Health policy Health politics Health reform Medical innovation Medicines Money and health Pharmaceutical Trust

The Gap Between the Trump Administration’s Promise of Reducing Rx Costs for Consumers and What People Really Want

Health Populi

Smart Pharmaceuticals Index (NQSSPH) from May 11, 2018, the date when POTUS and Secretary Azar made their announcement.